Using atropine eyedrops to treat myopia in children
Official title: Atropine 0.01% Eyedrops for Evolutive Myopia Treatment in Children. MYOPSTOP
Run by Centre Hospitalier Universitaire de Saint Etienne · NCT04252989 · Data updated 2026-11-12
This study tests whether daily atropine eyedrops can help children with worsening nearsightedness see better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 18 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne Academic / other |
| Locations | 1 site (Saint-Etienne) |
| Status | Recruiting |
| Started | December 18, 2019 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | March 18, 2025 |
| Trial ID | NCT04252989 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children with active myopia who are being treated with atropine 0.01% eyedrops.
✕Probably not a fit
Patients who may not benefit from this study include those who are non-compliant with the treatment regimen.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on the treatment of evolutive myopia in children using atropine 0.01% eyedrops, administered once daily. The study aims to collect data on the effectiveness of this treatment, which has shown promising results in clinical practice since 2017 at the hospital of Saint-Etienne. By building a comprehensive database, the investigators hope to publish their findings and share their experiences regarding the treatment of myopia in the French pediatric population.
Why it matters
Potential benefit: If successful, this treatment could significantly slow the progression of myopia in children, potentially reducing the risk of severe vision complications later in life.
How similar studies have gone: Other studies have shown promising results with atropine treatment for myopia, indicating that this approach is supported by existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children with active myopia treated with ATROPINE 0.01% eye drops * patient affiliated with a social security organization * agreement of both parents Exclusion Criteria: * non compliance with treatment
Where it's running
-
CHU de Saint Etienne
Saint-Etienne, France Recruiting
Study contacts
- Principal investigator: Marie Caroline TRONE — CHU de Saint Etienne
- Study coordinator: Marie Caroline TRONE
- Email: m.caroline.trone@chu-st-etienne.fr
- Phone: 04 77 82 94 28
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating a device for screening vision problems in young children
This study is testing a new device to see if it can effectively find vision problems in children aged 3 to 8, whether they wear glasses or not.
-
Optimizing light exposure to prevent and control myopia in children
This study tests if changing classroom lighting to mimic sunlight or using a smartphone app to guide light exposure can help prevent and control myopia in primary school children.
-
Hyperopic reserve screening for kindergartners in Beijing
A population-wide screening tests whether senior kindergarten children in Beijing have enough hyperopic reserve to help prevent future myopia.
-
Do dual-focus multifocal contact lenses improve hand-eye coordination and sports vision compared with your usual lenses
This study tests whether wearing dual-focus multifocal contact lenses improves hand-eye coordination and sports vision in adults who play baseball or softball and normally wear contact lenses.
-
Two monthly silicone hydrogel multifocal toric contact lenses in wearers with astigmatism and myopia
This study tests whether two popular soft multifocal toric contact lenses perform differently in adults who need vision correction for astigmatism and myopia.
-
Seeing clearly in low light after Ray-Tracing guided LASIK
A trial tests how well WaveLight Plus LASIK works for people with myopia and astigmatism and whether patients are satisfied after the procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.